• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tela Bio Inc (NQ: TELA )

    2.440 +0.060 (+2.52%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 30,023
    Open 2.390
    Bid (Size) 1.990 (1)
    Ask (Size) 3.000 (1)
    Prev. Close 2.380
    Today's Range 2.350 - 2.460
    52wk Range 2.300 - 7.840
    Shares Outstanding 24,713,798
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Demystifying TELA Bio: Insights From 6 Analyst Reviews
    Via Benzinga
    Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
    Via Benzinga
    Exposures Fossil Fuels

    Performance

    YTD
    -63.14%
    -63.14%
    1 Month
    -6.15%
    -6.15%
    3 Month
    -48.09%
    -48.09%
    6 Month
    -48.09%
    -48.09%
    1 Year
    -60.65%
    -60.65%

    More News

    Read More
    S&P 500 Gains 1%; Home Depot Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
    Via Benzinga
    TELA Stock Earnings: TELA Bio Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
    From TELA Bio, Inc.
    Via GlobeNewswire
    Recap: TELA Bio Q4 Earnings
    Via Benzinga
    Preview: TELA Bio's Earnings
    Via Benzinga
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce Second Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Appoints Jeffrey Blizard to its Board of Directors
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Appoints Greg Firestone as Chief Commercial Officer
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    TELA Bio Reports First Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce First Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
    From TELA Bio, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 21, 2024
    Via Benzinga
    TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.